191 related articles for article (PubMed ID: 22503130)
21. Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.
Spasojevic I; Batinic-Haberle I; Reboucas JS; Idemori YM; Fridovich I
J Biol Chem; 2003 Feb; 278(9):6831-7. PubMed ID: 12475974
[TBL] [Abstract][Full Text] [Related]
22. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.
Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
[TBL] [Abstract][Full Text] [Related]
25. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
[TBL] [Abstract][Full Text] [Related]
26. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.
Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
J Endourol; 2012 Nov; 26(11):1420-4. PubMed ID: 22783812
[TBL] [Abstract][Full Text] [Related]
27. Mn(III) meso-tetrakis-(N-ethylpyridinium-2-yl) porphyrin mitigates total body irradiation-induced long-term bone marrow suppression.
Li H; Wang Y; Pazhanisamy SK; Shao L; Batinic-Haberle I; Meng A; Zhou D
Free Radic Biol Med; 2011 Jul; 51(1):30-7. PubMed ID: 21565268
[TBL] [Abstract][Full Text] [Related]
28. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
[TBL] [Abstract][Full Text] [Related]
29. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.
Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I
Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553
[TBL] [Abstract][Full Text] [Related]
30. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
[TBL] [Abstract][Full Text] [Related]
32. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.
Batinic-Haberle I; Rajic Z; Benov L
Anticancer Agents Med Chem; 2011 May; 11(4):329-40. PubMed ID: 21355843
[TBL] [Abstract][Full Text] [Related]
33. Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP
Rajic Z; Tovmasyan A; de Santana OL; Peixoto IN; Spasojevic I; do Monte SA; Ventura E; Rebouças JS; Batinic-Haberle I
J Inorg Biochem; 2017 Apr; 169():50-60. PubMed ID: 28131001
[TBL] [Abstract][Full Text] [Related]
34. Detailed mechanism of the autoxidation of N-hydroxyurea catalyzed by a superoxide dismutase mimic Mn(III) porphyrin: formation of the nitrosylated Mn(II) porphyrin as an intermediate.
Kalmár J; Biri B; Lente G; Bányai I; Budimir A; Biruš M; Batinić-Haberle I; Fábián I
Dalton Trans; 2012 Oct; 41(38):11875-84. PubMed ID: 22911446
[TBL] [Abstract][Full Text] [Related]
35. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.
Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516
[TBL] [Abstract][Full Text] [Related]
36. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
[TBL] [Abstract][Full Text] [Related]
37. Comparative studies on manganese-based SOD mimetics, including the phosphate effect, by using global spectral analysis.
Friedel FC; Lieb D; Ivanović-Burmazović I
J Inorg Biochem; 2012 Apr; 109():26-32. PubMed ID: 22366231
[TBL] [Abstract][Full Text] [Related]
38. A potent superoxide dismutase mimic: manganese beta-octabromo-meso-tetrakis-(N-methylpyridinium-4-yl) porphyrin.
Batinić-Haberle I; Liochev SI; Spasojević I; Fridovich I
Arch Biochem Biophys; 1997 Jul; 343(2):225-33. PubMed ID: 9224734
[TBL] [Abstract][Full Text] [Related]
39. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
[TBL] [Abstract][Full Text] [Related]
40. Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.
Spasojević I; Chen Y; Noel TJ; Yu Y; Cole MP; Zhang L; Zhao Y; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2007 Apr; 42(8):1193-200. PubMed ID: 17382200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
